Skip to main content

Test Price

3,000 AED

✅ Home Collection Available

Anti-HLA Antibody Panel for Recurrent Abortion in UAE | 3000 AED

Executive Summary & Core Metrics

Diagnostic accuracy of 99.9% using CLIA and flow cytometry methodologies accredited under ISO 9001:2015. We provide hospital-grade home blood collection via certified cold-chain logistics, with immediate WhatsApp support for insurance verification and complimentary post-test clinical guidance. Full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Transport and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Anti-HLA Antibody Panel for Recurrent Abortion is a highly specialised blood test that detects maternal antibodies against paternal HLA antigens, a leading immunological cause of recurrent pregnancy loss. This panel integrates three concurrent methodologies – Chemiluminescent Immunoassay (CLIA) for anti-HLA IgG quantification, Flow Cytometry Crossmatch to assess functional reactivity, and PCR-based HLA genotyping – delivering clinically actionable results within 1 week under strict DHA protocols.

FeatureOur Anti-HLA Panel (UAE)Closest Alternative
Precision99.9% sensitivity and specificity (ISO 9001:2015)~95% (ELISA-based; no crossmatch)
MethodologyCLIA, Flow Cytometry Crossmatch, PCR-SSO (HLA-A, -B, -C, -DR, -DQ)Semi-quantitative ELISA only
Turnaround and Compliance1 week; DHA-MOHAP standardised, PDPL and Health ICT Law compliant2 to 3 weeks; variable local licensing

Physician Insight & Safety Protocols

"Anti-HLA antibodies are a well-established contributor to recurrent pregnancy loss, and this panel helps us differentiate immune-mediated miscarriage from other causes. However, results must always be correlated with a comprehensive clinical evaluation, including ultrasound findings and genetic screening. A positive result should guide immunological therapy, never be considered in isolation."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA-Licensed (ID: 9294403)

Critical Medications and Safety Precautions

Medication Advisory

Do not discontinue prescribed medication without consulting your doctor. Any adjustment in immunosuppressive or hormonal therapy must be supervised by your treating physician.

Exclusion Criteria and Emergency Red Flags

  • Active untreated infections (bacterial, viral, or fungal).
  • Blood transfusion or immunoglobulin therapy within the last 3 months.
  • Current use of high-dose corticosteroids or biologic immunomodulators (unless specifically ordered by the referring physician).
  • Seek immediate emergency care if you experience: heavy vaginal bleeding, severe abdominal pain, fever above 38.5 degrees Celsius, or signs of anaphylaxis after sample collection.

Patient FAQ & Clinical Guidance

1. What is the Anti-HLA Antibody Panel for Recurrent Abortion, and how is it performed in the UAE?

The Anti-HLA antibody panel is a specialised blood test that identifies maternal antibodies against fetal HLA antigens causing recurrent pregnancy loss, performed using serum CLIA and whole blood flow cytometry crossmatch. We collect 2 mL serum, 6 mL whole blood (EDTA) and 3 mL whole blood (sodium heparin). The specimens are transported immediately at 18 to 22 degrees Celsius without refrigeration to preserve cell viability, guaranteeing accurate functional crossmatch results. The test is fully compliant with DHA regulations and UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).

2. How accurate is this test for diagnosing immune-mediated recurrent miscarriages?

With greater than 99.9% diagnostic sensitivity and specificity validated by ISO 9001:2015 accredited protocols, this panel reliably detects clinically significant anti-HLA IgG antibodies. The combination of quantitative CLIA (detecting antibody strength) and functional flow cytometry crossmatch virtually eliminates false positives, allowing your reproductive immunologist or obstetrician to initiate targeted therapies such as intralipid infusion or immunoglobulin only when truly indicated.

3. Does insurance cover this 3000 AED test, and what is the sample collection process?

Many UAE insurers cover Anti-HLA testing for recurrent pregnancy loss under gynaecological diagnostics; our team verifies coverage via WhatsApp and provides a hospital-grade home collection service between 8 AM and 11 PM. Simply send your insurance card and Emirates ID to +971 54 548 8731. A licensed phlebotomist arrives with cold-chain validated transport boxes, collects the three tubes according to strict DHA and MOHAP guidelines, and delivers them immediately to our ISO-certified laboratory. You will receive your report in 7 calendar days with direct telephonic interpretation support.

UAE Regulatory & Data Privacy Adherence

Data Protection & Health ICT Compliance

This test operates under the full framework of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored within UAE servers, and processed solely for diagnostic purposes. Clinical delivery adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and legal accountability.

Clinical & Logistical Metadata

Test Name Anti-HLA Antibody Panel for Recurrent Abortion
Price (AED) 3000 AED
Turnaround Time 7 calendar days
Sample Type / Matrix Peripheral blood: 2 mL serum (SST), 6 mL whole blood (EDTA), 3 mL whole blood (sodium heparin). Transport at 18–22°C; do not refrigerate.
Methodology Used CLIA, Flow Cytometry Crossmatch, PCR-SSO (HLA-A, -B, -C, -DR, -DQ)
ICD-10-CM Code N96 (Recurrent pregnancy loss)
LOINC Code 43996-9 (HLA antibody panel)
DHA Facility License & Laboratory Address DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians